Regulatory Solutions to the Problem of High Generic Drug Costs
MetadataShow full item record
CitationLuo, Jing, Ameet Sarpatwari, and Aaron S. Kesselheim. 2015. “Regulatory Solutions to the Problem of High Generic Drug Costs.” Open Forum Infectious Diseases 2 (4): ofv179. doi:10.1093/ofid/ofv179. http://dx.doi.org/10.1093/ofid/ofv179.
AbstractRecent reports have highlighted dramatic price increases for several older generic drugs, including a number of essential products used to treat deadly infectious diseases. Although most of these medicines have been widely available at reasonable prices for decades, some manufacturers have seized on unique features of the pharmaceutical marketplace to seek substantial profits. In this Perspective, we examine limitations in current price regulation among public and private payors and consider several reforms that could address the problem of expensive generic drugs through improved competition.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:23993703